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Changes in perception of treatment 
efficacy are associated to the 
magnitude of the nocebo effect and 
to personality traits
Nicole Corsi1,2, Mehran Emadi Andani1,3, Michele Tinazzi1 & Mirta Fiorio1
The nocebo effect in motor performance consists in a reduction of force and increase of fatigue 
following the application of an inert treatment that the recipient believes to be effective. This effect 
is variable across individuals and it is usually stronger if conditioning –exposure to the active effect 
of the treatment– precedes a test session, in which the treatment is inert. In the current explorative 
study we used a conditioning procedure to investigate whether subjective perception of treatment 
effectiveness changes between the conditioning and the test session and whether this change is related 
to dispositional traits and to the nocebo-induced reduction of force. Results showed that 56.1% of 
participants perceived the treatment as more effective in the test than in the conditioning session, had 
a more pronounced reduction of force, felt more effort and sense of weakness and were characterized 
by lower levels of optimism and higher anxiety traits compared to the other 43.9% of participants, who 
conversely perceived the treatment as less effective in the test session than in the conditioning. These 
findings highlight for the first time a link between changes in perception of treatment effectiveness, 
personality traits and the magnitude of the nocebo response in motor performance.
The nocebo effect can be defined as a negative outcome following the application of an inert treatment that the 
recipient believes to be effective1–3. In the context of motor performance, reduction of force and increase of fatigue 
have been described after the application of a nocebo procedure4–6, although the factors modulating this effect are 
still unclear, because most of the studies were carried out in the field of pain. Following new integrative models7, 
nocebo effects can be induced in different ways: with negative expectations8–11, associative learning12–14, partial 
conditioning15, social learning16,17 and even without conscious awareness and direct learning18. Moreover, an 
emerging factor in the placebo/nocebo literature is related to the way in which participants perceive the treat-
ment in terms of choice19 and also in terms of its effectiveness20. With this regard, it was demonstrated that the 
discrepancy between subject’s expectation and the perception of treatment effectiveness could evoke a placebo 
response20. Beliefs about treatments and perception of treatment effectiveness have an impact in the clinical con-
text21,22. Hence, these factors could represent an important psychological construct to be taken into account in 
nocebo, as well as placebo, studies in which the treatment does not have any active effect per se, but only simulates 
an active therapy in a particular psychosocial context23.
The current study is as an explorative investigation of the role of perception of treatment effectiveness on the 
nocebo effect in motor performance. More precisely, we investigated changes in perception of treatment effective-
ness by adopting a conditioning procedure, in which the recipient was surreptitiously exposed to the fake effects 
of a treatment and implicitly learned to associate the application of the treatment to force decrements5. Typically, 
at the end of the conditioning procedure, the treatment from neutral becomes conditioned23,24 and afterwards 
it can elicit a nocebo response even if it is applied without any effect. The first aim of this study is to investigate 
whether and how strongly individuals perceive the treatment as effective when passing from the conditioning 
phase, in which the effect of the treatment is present, to the test session, in which the effect is removed and the 
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nocebo response can be measured. This kind of investigation may help to better characterize individual differ-
ences in the nocebo effect in motor performance.
As we know from studies in pain perception, individuals differ in the tendency to express a nocebo response, 
depending on dispositional traits. Nocebo hyperalgesia is negatively predicted by optimism25,26 and positively 
predicted by anxiety12,26,27. Moreover, in the context of social observation, dispositional empathy and pain cat-
astrophizing are associated to nocebo effects16,17. In the current explorative investigation, the second aim is to 
investigate whether changes in perception of treatment effectiveness could be related to some personality traits. 
To this purpose we assessed not only optimism (Life-Orientation Test-Revisited28) and anxiety (State-Trait 
Anxiety Inventory29), but also other traits that have been found to predict analgesic placebo responses30, like 
dopamine-related personality traits (i.e., harm avoidance and novelty seeking) (Temperament and Character 
Inventory (TCI31). Moreover, since the nocebo effect is induced through verbal suggestion, we assessed suggesti-
bility (Multidimensional Iowa Suggestibility Scale32), in order to investigate whether the tendency to accept infor-
mation from others could be associated to the subjective perception of treatment effectiveness. Finally, in order 
to check any change in performance due to subjective motivation in performing the motor task, we also assessed 
intrinsic motivation (Intrinsic Motivation Inventory33,34).
With regards to the first aim of the study, based on the evidence that perception of treatment effectiveness can 
influence the clinical outcome21, we hypothesize that individuals who perceive the treatment as strongly effective 
at the end of the nocebo procedure will also show a more pronounced nocebo-induced reduction of force than 
those who less consistently perceive its effectiveness. With regards to the second aim, based on the studies demon-
strating stronger nocebo hyperalgesia in individuals with low levels of optimism and high levels of anxiety12,25–27, 
the hypothesis is that the same traits could be associated to the tendency to strongly perceive a negative effect of 
the treatment on motor performance.
Methods
Subjects. Forty-one right-handed (apart from three left-handed) healthy volunteers (18 women, mean age: 
22.66 ± 3.05 years) were recruited from the student population of the University of Verona. Their performance 
was preliminarily compared with that of a control group made of 20 right-handed (apart from two left-handed) 
subjects (9 women, mean age: 21.75 ± 2.24 years), in order to confirm the validity of the paradigm in inducing 
a nocebo effect (see Supplementary Information and Supplementary Fig. S1). Participants self-declared to have 
no history of medical problems, including neurological and psychiatric disease. Before starting the study, all the 
subjects signed an informed consent form in which the real research aims were omitted. Only after completing 
the whole experimental procedure, the nocebo nature of the study was explained. The study was approved by the 
local ethical committee of the Department of Neurological and Movement Sciences at the University of Verona 
and subjects had to sign an informed consent form prior to participation. The study was conducted in accordance 
with the approved guidelines. Power analysis on the sample size is reported in the Supplementary Information.
Motor task. The motor task consisted in abduction movements of the right index finger against a piston 
connected to a force transducer (DS BC302)5,35. The right hand was blocked by a device in order to exclude the 
contribution of other muscles except the first dorsal interosseous (FDI). In real-time, finger pressures against the 
piston were linearly converted into vertical displacements of a cursor shown on a PC monitor. In this way the 
subject could have a visual feedback of the amount of force. For each participant the maximum voluntary con-
traction (MVC) was measured before starting the experiment. This value was then used to calibrate the vertical 
displacements of the cursor on the PC monitor during the task. Subjects had to press the mouse with the left hand 
to initiate each single trial. In each trial, they were asked to press the piston with the right index finger as strongly 
as possible in order to bring the visible cursor into a target zone made of four colored horizontal lines which rep-
resented the 60%, 80%, 100% and 120% of the subject’s MVC. Each trial lasted 1100 ms.
Procedure. After general instructions, 5 trials were used to allow the subjects to familiarize with the instru-
mentation. Before starting the nocebo procedure, all the participants went through a training in which they had 
to perform the motor task for 50 trials (Fig. 1a). In the conditioning session, an inert treatment (10 Hz transcuta-
neous electrical nerve stimulation, TENS) was applied for 5 minutes over the region of the FDI muscle, together 
with the deceptive verbal instructions that it had the effect of reducing the recruitment of muscle fibers, with a 
consequent decrease in force production. The intensity of TENS was enough to produce a slight sensation on 
the skin, without producing muscle contraction or discomfort. Soon after TENS, participants performed the 
motor task (50 trials) with a surreptitious, stepwise, reduction of the cursor’s excursion range. More precisely, an 
attenuation coefficient was introduced and the excursion of the cursor was gradually decreased in steps of 0.0029 
from trial 1 to trial 35 and then it remained stable until the end of the session (from trial 36 to trial 50). Subjects 
were unaware of this manipulation that was meant as a procedure to condition them about the effects of TENS 
in reducing force. In order to monitor subjects’ belief about TENS, we asked them to judge its efficacy on a visual 
analog scale (VAS) (Fig. 1a,b). More precisely, after the execution of the motor task, subjects were asked to report 
how much the TENS treatment was effective in reducing their force, by means of a 10 cm VAS, ranging from 0 
(not effective) to 10 (very effective). In the test session, TENS was applied again with the same verbal instructions. 
Subjects then repeated the motor task (50 trials), but this time without any manipulation, that is without the 
reduction of the cursor’s excursion range. After the motor task, TENS efficacy score was measured again with the 
VAS (Fig. 1a,b). The difference of TENS efficacy scores between the test and conditioning sessions was taken as a 
proxy of the strength of perception of treatment efficacy (see in data handling for a detailed description).
Behavioral data. Force was evaluated through two indices. The first index was the mean value of the peak force 
amplitude (Forcepeak) computed in the 50 trials of each session and normalized to the MVC, as follows (1):
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The second index regarded the percentage of strong pressures (Strongpress) (2):
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where Ntot trials is the total number of trials in each session (i.e., 50) and Nstrong trials is the number of trials in which 
the peak force exceeded the mean value recorded in the training session. While the mean normalized force peak is 
a measure of the overall force level during a session, the percentage of strong pressures is a measure of consistency 
of behavior throughout a session.
Subjective data. In addition to TENS efficacy scores, other subjective variables were evaluated during the pro-
cedure: (i) Perception of force. After each session subjects had to estimate how strong they felt during the motor 
task by means of a 10 cm VAS scale appearing on the PC monitor, ranging from 0 (very weak) to 10 (very strong). 
(ii) Sense of effort. Subjective sense of effort was measured after the execution of the motor task with the Borg 
scale36, ranging from 6 (rest) to 20 (maximal effort). (iii) Expectation. Soon after the removal of TENS, before 
starting the motor task, subjects were asked to judge how they expected their performance will be. This judgment 
was given on a 7-points Likert scale, ranging from − 3 (much worse) to + 3 (much better) by taking as reference 
the training session. Expectation scores were measured twice, after each TENS application.
Personality Questionnaires. After the whole experimental procedure, we administered some personality 
questionnaires in order to evaluate the possible role of personality traits. All the questionnaires were computer-
ized (E-prime, version 2.0, Psychology Software Tools, Inc), in order to facilitate data collection and processing. 
In particular, we took into account: (i) State-Trait Anxiety Inventory (STAI)29. This is a 40-items inventory divided 
in two scales: STAI-I measures the level of anxiety in a precise moment and STAI-II refers to an individual’s 
usual anxiety tendency. In our study STAI-I was administered twice, before and after the procedure, to control 
for any change in the anxiety level across sessions, while STAI-II was applied only at the end of the procedure; 
(ii) Life-Orientation Test-Revisited (Lot-R)28. This is a 10-items scale developed to assess individual differences 
in generalized optimism versus pessimism. Four items are fillers and the total score is obtained by summing the 
answers of 6 real items; (iii) Temperament and Character Inventory (TCI)31. This 240-items questionnaire provides 
a personality profile in the context of a biopsychological model. It is made of four temperament and three char-
acter scales. The temperament dimensions are heritable traits and include novelty seeking (NS), harm avoidance 
Figure 1. Schematic representation of the experimental protocol. (a) After a first training session, a 
conditioning session was performed in which an inert treatment (TENS) was applied together with verbal 
instructions that it could induce a decrease of force and with a manipulation in which the visual feedback was 
surreptitiously reduced. After the motor task was completed, subjects were asked to judge TENS efficacy on a 
VAS ranging from 0 (not effective) to 10 (very effective). Afterwards, the procedure was repeated again in the 
test session, but this time the (fake) effect of TENS was removed. (b) Example of answers of participants who 
gave higher scores of TENS efficacy in the test compared to the conditioning session (dark blue, positive Δ 
TENS effectiveness score), and participants who gave lower scores in the test compared to the conditioning 
(light blue, negative Δ TENS effectiveness score).
www.nature.com/scientificreports/
4Scientific RepoRts | 6:30671 | DOI: 10.1038/srep30671
(HA), reward dependence (RD) and persistence (P). The character dimensions may be related to different cog-
nitive systems and include self-directedness (SD), cooperativeness (C) and self-transcendence (ST). One subject 
did not complete the TCI questionnaire due to recording problems; (iv) Multidimensional Iowa Suggestibility 
Scale (MISS)32. This is a 95-items questionnaire to measure social and psychological suggestibility defined as 
a tendency to accept messages from others. It is made of five suggestibility sub-scales: consumer suggestibility, 
persuadability, physiological suggestibility, physiological reactivity and peer conformity. To the purposes of the 
current study, we considered the total suggestibility score; (v) Intrinsic Motivation Inventory (IMI)33,34. This is 
a 37-items multidimensional inventory to assess participants’ subjective experience related to a target activity 
in laboratory experiments. It is divided in different scales assessing participant’s interest/enjoyment, perceived 
competence and choice, effort perceived during the laboratory activity, value/usefulness of the performed activity 
and pressure and tension felt during the activity. To the purposes of the current study, we considered the total 
intrinsic motivation score.
Data handling and statistics. The variable of interest in our study was the perception of treatment effec-
tiveness computed as difference between the test and the conditioning session (Δ TENS effectiveness). The two 
sessions (conditioning and test) were characterized by different visual feedbacks: during the conditioning session 
there was a surreptitious reduction of the cursor’s excursion range that should simulate the effect of TENS on 
force decrease. The cursor’s reduction was not applied in the test session. Hence, Δ TENS effectiveness represents 
whether and how strongly participants perceived the treatment as effective in the test compared to the condi-
tioning session. This variable (Δ TENS effectiveness) was handled following two different statistical approaches.
In the first statistical approach, the polarity of the difference (positive or negative) was considered as means 
to define two groups (Fig. 1b). Conceptually, the two groups belong to two categories with opposite patterns of 
subjective perception: participants with a positive difference perceived the effect of the treatment more strongly 
in the final than in the conditioning session, whereas those with a negative difference were not so strongly con-
sistent in their perception of treatment effectiveness. Based on this assumption, we aimed at characterizing the 
two categories in terms of sample size, gender distribution, performance at the motor task, and personality traits 
by adopting a mixed design with between and within factors. The hypothesis in this analysis is that the group with 
a positive TENS difference (indicating stronger perception of the negative effects of the treatment effectiveness 
in the test session) should also show a more pronounced nocebo effect in the behavioral (reduction of force) 
and subjective outcomes (feeling weakness and effort) than the group with a negative difference (indicating less 
perception in the negative effects of the treatment effectiveness in the test session). Based on studies in pain per-
ception26,27, we also hypothesize that the group with a positive TENS difference should present higher levels of 
anxiety and lower levels of optimism than the groups with a negative difference.
For this analysis, first we checked that the two groups (positive vs. negative Δ TENS effectiveness) had similar 
MVC and motor performance (in terms of normalized Forcepeak) in the training session, by means of t-test for 
independent samples. Then, we analyzed the behavioral parameters (normalized Forcepeak, Strongpress) and the 
subjective parameters (TENS effectiveness scores, subjective perception of force, sense of effort and expectation 
scores) in the two crucial experimental conditions (conditioning vs. test) by means of repeated measures analyses 
of variance (rmANOVAs) with Group as between-subject factor (positive vs. negative Δ TENS effectiveness) and 
Session as within-subject factor (conditioning vs. test). In addition to all the indices of performance described 
above, we computed also the difference (Δ ) between the test and the conditioning sessions, as computational 
measure to evaluate the changes of the behavioral and subjective variables in the two groups. For each variable, 
the ∆ of the two groups were compared by means of t-tests for independent samples. The mean scores of the two 
groups at the personality questionnaires were analyzed with t-tests for independent samples. In all the analyses, 
post-hoc comparisons were executed by means of t-tests for paired or independent samples, using the Bonferroni 
correction for multiple comparisons where necessary. The level of significance was set at p < 0.05. All the data are 
expressed as mean ± s.e.m.
In a second statistical approach, we adopted a within design by considering all the subjects together and by 
dealing the difference in perception of treatment effectiveness as a continuum (from negative to positive values). 
The rationale for this approach is to prove whether changes in perception of treatment effectiveness were asso-
ciated to changes in performance at the motor task and to personality traits. To this purpose, the difference in 
TENS effectiveness scores was correlated with the difference between the test and the conditioning sessions at 
the motor task (i.e., Δ normalized Forcepeak, Δ Strongpress, Δ subjective perception of force, Δ sense of effort and 
Δ expectation). The hypothesis in this analysis is that more positive TENS effectiveness difference (indicating 
stronger perception in the negative effects of the treatment effectiveness in the test session), would be associated 
to a stronger nocebo effect measured as changes in the behavioral and subjective variables. Because we had a 
specific hypothesis about the direction of these correlations, 1-tailed test was used.
Difference of TENS effectiveness scores was correlated also with the personality variables. Although for 
some personality traits (like anxiety and lower levels of optimism ) we could have specific hypotheses about the 
direction of the correlations26,27, for other traits (like intrinsic motivation and the temperament and character 
dimensions) it was not possible to make precise hypotheses and therefore 2-tailed test was used. No multiple 
comparisons were applied to the correlations, due to the explorative nature of the study.
Analyses were performed by using SPSS Statistics 21 software (SPSS Inc).
Results
Mixed design. Levene’s test revealed homogeneous variances of all the data, apart from feeling of force 
(p = 0.002), which was analyzed with non-parametric tests (Mann-Whitney test for comparisons between groups 
and Wilcoxon signed-ranks test for comparisons across sessions).
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Following the first statistical approach, we found that 56.1% of the subjects (23 out of 41 subjects) had a posi-
tive difference of TENS effectiveness scores, indicating that they perceived more effect in the test than in the con-
ditioning session (Fig. 2). Among these, 11 were females and 12 males, the mean age of the group was 22.57 ± 3.27 
years and mean education was 15.3 ± 1.49 years. The remaining 43.9% of the subjects (18 out of 41) had a negative 
difference of TENS effectiveness scores, indicating that they perceived less effect of TENS in the test than in the 
conditioning session (Fig. 2). Among these, seven were females and 11 males, the mean age of the group was 
22.78 ± 2.84 years and mean education was 15.29 ± 1.72 years. The two groups did not statistically differ for age 
(independent samples t-test, t(39) = − 0.218; p = 0.828) and for gender distribution (Chi-square test, χ 2 = 0.327, 
df = 1, p = 0.567). Moreover, the two groups did not statistically differ for MVC, measured in the initial calibra-
tion phase (positive Δ TENS effectiveness: 20.53 ± 0.60 N, negative Δ TENS effectiveness: 19.41 ± 0.83 N, inde-
pendent sample t-test, t(39) = 1.122, p = 0.269). Finally, the two groups had also similar normalized Forcepeak in 
the training session (positive Δ TENS effectiveness: 89.33% ± 1.46, negative Δ TENS effectiveness: 90.1% ± 1.54, 
independent sample t-test, t(39) = − 0.351, p = 0.727). These findings suggest that at the beginning of the experi-
mental procedure, the two groups had comparable behavioral performance.
ANOVA on normalized Forcepeak measured during the nocebo procedure, revealed a significant effect of 
Session [F(1,39) = 32.65, p < 0.001, η 2 = 0.456], due to lower values in the test (80.45% ± 1.56) compared to the 
conditioning (85.38% ± 1.40) session and a non-significant effect of Group [F(1,39) = 0.112, p = 0.740, η 2 = 0.003]. 
The interaction Session × Group was significant [F(1,39) = 4.46, p = 0.041, η 2 = 0.103]. Post-hoc comparisons 
showed that the group with positive Δ TENS effectiveness was weaker in test (79.06% ± 1.88) compared to the 
conditioning (85.81% ± 2) session (p < 0.001) and also the negative Δ TENS effectiveness group was weaker in 
the test (81.83% ± 2.58) compared to the conditioning (84.94% ± 1.87) session (p = 0.023) (Fig. 3a). Analysis 
of Δ Forcepeak disclosed a significant difference between groups (t(39) = − 2.111, p = 0.041) (Fig. 3b), suggesting 
that positive and negative Δ TENS effectiveness groups had a different nocebo response in terms of behavioral 
outcome.
ANOVA on Strongpress disclosed a similar pattern of results with a significant effect of Session [F(1,39) = 16.33, 
p < 0.001, η 2 = 0.295], due to lower values in the test (18.12% ± 4.23) than in the conditioning (30.22% ± 4.55), 
but no effect of Group [F(1,39) = 0.45, p = 0.834, η 2 = 0.001]. The interaction Session × Group was significant 
[F(1,39) = 7.59, p = 0.009, η 2 = 0.163]. Post-hoc comparisons showed that the positive Δ TENS effectiveness group 
had a significant reduction in the percentage of strong pressure in the test (14.87% ± 4.81) compared to the condi-
tioning (35.22% ± 6.16) session (p < 0.001), while no difference was found in the negative Δ TENS efficacy score 
group (p = 0.199) (Fig. 3c). Analysis of Δ Strongpress disclosed a significant difference between groups (t(39) = 
− 2.955, p = 0.006) (Fig. 3d). These findings confirm a different nocebo effect in performance between positive 
and negative Δ TENS effectiveness groups.
TENS efficacy scores were analyzed to confirm that the two groups were not only qualitative, but also quantitatively 
different concerning their belief in the treatment efficacy. ANOVA on TENS efficacy scores showed that on average 
the two groups had significantly different judgments about TENS, especially in the test session (that is in the second 
application of TENS). The factor Session was significant [F(1,39) = 4.23, p = 0.047, η 2 = 0.098], due to lower values in 
the test (4.69 ± 0.38) than in the conditioning (5.07 ± 0.36) session, but no effect of Group [F(1,39) = 2.27, p = 0.140, 
η 2 = 0.055] was found. The Session × Group interaction was significant [F(1,39) = 76.74, p < 0.001, η 2 = 0.663]. Post-hoc 
Figure 2. Description of the positive and negative Δ TENS effectiveness groups. By subtracting the scores of 
TENS efficacy in the test and conditioning sessions, it turned out that 23 participants had a positive difference 
(positive Δ TENS effectiveness) and 18 had a negative difference (negative Δ TENS effectiveness).
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comparisons showed that positive Δ TENS effectiveness group reported higher values in the test (6.03 ± 0.51) com-
pared to the conditioning session (4.82 ± 0.51, p < 0.001), while the opposite pattern was found in the negative Δ 
TENS effectiveness group, with lower values in the test (3.37 ± 0.55) than in the conditioning session (5.32 ± 0.49, 
p < 0.001) (Fig. 4a). Moreover, the two groups had significantly different values in the test session (p = 0.001). Analysis 
of the Δ TENS efficacy scores confirmed a different pattern between the two groups (t(39) = 7.943; p < 0.001). These 
findings confirm a different belief in the treatment between positive and negative Δ TENS effectiveness groups.
Wilcoxon signed-ranks test on force perception disclosed that the participants with positive Δ TENS effec-
tiveness had lower scores in the test (3.71 ± 0.36) compared to the conditioning (4.36 ± 0.28) session (Z = − 2.5, 
p = 0.012), whereas participants with negative Δ TENS effectiveness showed no difference between sessions 
(Z = − 1.66, p = 0.098) (Fig. 4b). Mann-Whitney test on the Δ force perception showed a significant difference 
between the two groups (U = 96.5, Z = − 2.905, p = 0.004). These findings suggest that positive and negative Δ 
TENS effectiveness groups had a different nocebo response even in terms of subjective feeling of force.
ANOVA on the sense of effort revealed a non-significant effect of Session [F(1,39) = 0.025, p = 0.876, 
η 2 = 0.001] and Group [F(1,39) = 2.36, p = 0.133, η 2 = 0.057]. However, the Session × Group interaction was significant 
[F(1,39) = 5.05, p = 0.030, η 2 = 0.115]. Post-hoc comparisons showed that the positive Δ TENS effectiveness group 
perceived a higher level of effort in the test (14.52 ± 0.45) than in the conditioning (12.52 ± 0.3) session (p < 0.001), 
while the negative Δ TENS effectiveness group had no differences between sessions (p = 0.217). Moreover, the two 
groups were different in the test session (p = 0.049) (Fig. 4c). Analysis of Δ sense of effort disclosed significant dif-
ferences between groups (t(39) = 2.247, p = 0.030). Hence, from these findings we can conclude that the sense of effort 
after a nocebo procedure is related to the amount of belief in the negative effects of the treatment.
Figure 3. Behavioral data. (a) Normalized Forcepeak of the two groups in the conditioning and test sessions. 
A significant decrease of force could be observed only in the group with positive Δ TENS effectiveness score. 
(b) Δ of normalized Forcepeak: the group of positive Δ TENS effectiveness score had a more marked decrease 
of force than the negative Δ TENS effectiveness score. The numbers on the y-axis are order from 0 to negative 
values. (c) Percentage of Strongpress in the two groups and in the two sessions. A significant reduction of strong 
pressures was found in the group of negative Δ TENS effectiveness score. (d) Δ of percentage of Strongpress: the 
group of positive Δ TENS effectiveness score had a more marked decrease of strong pressures than negative 
Δ TENS effectiveness score. The numbers on the y-axis are ordered from 0 to negative values. All the data are 
expressed as mean values and standard errors (s.e.m.). * * p < 0.01, * p < 0.05.
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Analysis of expectation scores showed that the factor Session was significant [F(1,39) = 16.62, p < 0.001, 
η 2 = 0.299], due to more negative values in the test (− 1.45 ± 0.12) compared to the conditioning session 
(− 0.84 ± 0.10) (Fig.  4d). Conversely, the factor Group [F(1,39) = 0.04, p = 0.838, η 2 = 0.001] and the 
Figure 4. Subjective and personality data. (a) TENS efficacy scores of the two groups in the two sessions. 
In the conditioning session the two groups had similar scores of TENS efficacy, whereas in the test session 
the group of positive Δ TENS effectiveness score had higher scores than the group of negative Δ TENS 
effectiveness score. Moreover, while the group of positive Δ TENS effectiveness score had higher scores in the 
test compared to the conditioning session, the groups of negative Δ TENS effectiveness score had the opposite 
pattern, with lower scores in the test compared to the conditioning session. This suggests that the two groups 
were not only qualitatively, but also quantitatively different in their belief. (b) Subjective perception of force 
of the two groups in the two sessions. The group of positive Δ TENS effectiveness score felt weaker in the test 
compared to the conditioning session, whereas negative Δ TENS effectiveness score had a stable feeling of 
force. (c) Sense of effort at the BORG scale (Borg, 1970). The group of positive Δ TENS effectiveness score 
showed a significant increase of sense of effort in the test compared to the conditioning session. (d) Expectation 
of performance of the two groups in the two sessions. Expectation was measured soon after TENS application 
and before task execution. The scores of the two groups were not different both before the conditioning session 
and before the test session. (e) STAY II total score showed that positive Δ TENS effectiveness score had higher 
scores than negative Δ TENS effectiveness score. (f) Analysis showed a tendency of difference in total Lot-R 
score between positive and negative Δ TENS effectiveness score. All the data are expressed as mean values and 
standard errors (s.e.m.). * * p < 0.01, * p < 0.05, ~p = 0.051.
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Session × Group interaction [F(1,39) < 0.01, p = 0.994, η 2 = 0.000] were not significant. Moreover, the analysis of 
Δ expectation scores showed no significant differences between groups (p = 0.994). These findings suggest that 
expectation was not different between positive and negative Δ TENS effectiveness groups and therefore it could 
be unrelated to the amount of persistence of belief in the treatment. Contingency tables on the distribution of 
expectation scores in the two sub-groups are reported in the Supplementary Information (see Supplementary 
Tables 1 and 2).
With regards to the personality traits, t-test for independent samples revealed that the positive Δ TENS effec-
tiveness group had higher STAI-II (assessing trait anxiety) scores (46.04 ± 1.73) than the negative Δ TENS effec-
tiveness group (40.33 ± 1.93) (t(39) = 2.200, p = 0.034), indicating that the former was generally more anxious than 
the latter (Fig. 4e).
Analysis of Lot-R (assessing optimism and pessimism) revealed a nearly significant difference between the 
two sub-groups (t(39) = − 2.012, p = 0.051) with lower scores in participants with positive Δ TENS effectiveness 
(12.61 ± 0.83) compared to those with negative Δ TENS effectiveness (15.22 ± 1.02), suggesting that the former 
were more pessimist than the latter (Fig. 4f).
Within design. Following the second statistical approach, we found that Δ TENS effectiveness scores neg-
atively correlated with Δ normalized Forcepeak (rho = − 0.284, p = 0.036), with Δ Strongpress (rho = − 0.282, 
p = 0.037) and with Δ subjective perception of force (rho = − 0.542, p < 0.001) and positively correlated with 
Δ sense of effort (rho = 0.278, p = 0.039). These findings suggest that a more positive difference in perception 
of TENS effectiveness was associated to a more pronounced reduction of force, reduction of feeling of force and 
stronger sense of effort during the nocebo procedure (Fig. 5).
With regards to personality traits, scores at the STAI-II positively correlated with the Δ TENS effectiveness 
scores (rho = 0.335, p = 0.033), suggesting that the higher the anxiety trait, the stronger the perception of the 
negative effects of TENS in the test session (Fig. 6a).
A negative correlation with the Δ TENS effectiveness scores and Lot-R (rho = − 0.373, p = 0.016), suggesting 
that the lower dispositional optimism the stronger the perception of the negative effects of TENS in the test ses-
sion (Fig. 6b). Analysis of the TCI revealed positive correlations between Δ TENS effectiveness scores and harm 
avoidance scale (assessing behavioral inhibition) (rho = 0.321, p = 0.044) (Fig. 6c), indicating that the most inhib-
ited individuals more strongly perceived the negative effects of TENS in the test session. A negative correlation 
was found with persistence (assessing perseverance in spite of fatigue or frustration) (rho = − 0.367, p = 0.020), 
suggesting that those individuals who were weaker in resisting to fatigue perceived more strongly the negative 
effects of TENS (Fig. 6d). No other correlations were found to be significant.
Figure 5. Correlations between Δ TENS efficacy scores and behavioral data. (a) Δ TENS effectiveness 
scores negatively correlated with Δ normalized Forcepeak (a), (b) Δ Strongpress and with (c) Δ subjective 
perception of force. (d) Δ TENS effectiveness scores positively correlated with Δ sense of effort.
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Discussion
The findings of this study show that changes in the perception of treatment effectiveness are associated to the 
magnitude of the nocebo effect in motor performance and to personality traits. The same nocebo procedure, con-
sisting of conditioning and verbal suggestion, was applied to all the participants. However, when the subjects were 
asked about the efficacy of the treatment in reducing force, two different patterns of response could be observed: 
Some subjects gave higher scores of TENS effectiveness in the test than in the conditioning session, whereas other 
subjects gave lower scores in the test than in the conditioning session. Of note, the two sessions were different 
only with respect to the surreptitious reduction of the cursor’s excursion range, which was applied in the condi-
tioning session and removed in the test session. This manipulation served as a means to expose the participants 
to the effect of TENS in reducing force, thus strengthening their belief about it. In the test session, however, TENS 
was applied without manipulation and the pure nocebo response could be measured. Interestingly, depending 
on the change in perception of TENS effectiveness between the test and conditioning sessions, different nocebo 
responses could be observed in terms of behavioral and subjective outcomes.
With regards to the behavioral outcome, it should be first noticed that the paradigm was suitable to induce a 
behavioral nocebo effect, as also certified by the preliminary comparison with a control group. By dividing the 
subjects in relation to changes in the perception of TENS effectiveness we found that force production was differ-
ently affected in the two sub-groups. Although reduction of normalized force was observed in both sub-groups, 
a more pronounced decrease of percentage of strong pressures was found in individuals with a positive differ-
ence of perception of TENS effectiveness. The two indexes of performance represent slightly different aspects: 
Normalized force is a measure of the mean force level in relation to the MVC, whereas the percentage of strong 
pressures gives a measure of the consistency of behavior. Namely, the latter parameter of motor performance 
represents how consistently participants pressed the piston above a certain value (as determined in the training 
session). This finding suggests that individuals who strongly believed in the negative effects of the treatment were 
also less able to exert strong pressures on the piston than those who less consistently perceive the effects of the 
treatment. The negative correlations between changes in perception of treatment effectiveness and force reduction 
indicate that the more the negative effects of the treatment are perceived at the end of the nocebo procedure the 
stronger is the reduction of force. Overall, the behavioral results unmask a link between changes in perception 
Figure 6. Correlations between Δ TENS efficacy scores and personality traits. (a) STAY-II scores positively 
correlated with the Δ TENS efficacy scores, suggesting that higher levels of trait anxiety were associated to 
higher tendency to believe in the negative effects of the treatment. (b) Lot-R scores negatively correlated with 
the Δ TENS efficacy scores, suggesting that lower levels of optimism were associated to higher tendency to 
believe in the negative effects of the treatment. (c) TCI-harm avoidance total score positively correlated with Δ 
TENS efficacy scores, suggesting that more inhibited, pessimist and worried individuals had a higher tendency 
to believe in the negative effects of the treatment. (d) TCI-persistence negatively correlated with Δ TENS 
efficacy scores, suggesting that individuals who resisted less to fatigue had a higher tendency to believe in the 
negative effects of the treatment.
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of treatment effectiveness and the magnitude of the nocebo effect. The mechanisms at the basis of these findings, 
however, remain to be clarified in future studies.
With regards to the subjective variables, participants with a positive difference of perception of TENS effec-
tiveness felt more weakness and effort in the test than in the conditioning session, while those with a negative dif-
ference of perception of TENS effectiveness did not modify the feeling of force and sense of effort across sessions. 
Interestingly, after TENS application both groups expected a similar worsening of performance. Expectation was 
measured twice: before the conditioning procedure and before the test session. In the first case, subjects’ expec-
tation may have been influenced by the experimenter’s information about the treatment, prior to experience, 
whereas in the second case their expectation may have been influenced not only by the experimenter’s informa-
tion, but also by the exposure to the effects of TENS during the conditioning phase. The fact that both groups gave 
similar scores at the expectation scale suggests that the procedure was successful in deceiving the subjects and 
that the different perception of TENS effectiveness was not triggered by different expectation levels. A challenge 
for future research on placebo and nocebo effects will be to investigate whether expectation and perception of 
treatment efficacy could be considered as two independent or interacting cognitive processes.
An interesting question in the placebo/nocebo literature is the definition of a placebo/nocebo-prone person-
ality37,38. Differently from previous studies, we adopted a new approach, by taking into account the changes in 
perception of treatment effectiveness between the test and the conditioning session. The inspection of disposi-
tional factors revealed that personality traits like anxiety and TCI-harm avoidance (which is indicative of inhib-
ited behavior31,39) were positively correlated with the tendency to perceive the negative effects of the treatment, 
whereas optimism and TCI-persistence (which implies continuing and persevering despite fatigue and lack of 
reward40) were negatively correlated.
These findings well fit with the notion that optimism and anxiety modulate nocebo, as well as placebo, 
responses12,25,26,41. Geers and colleagues25 found that when participants were told that a pill would have made 
them feel unpleasant, pessimists were more likely than optimists to report the expected negative symptoms. 
Moreover, in a previous study in the context of pain, a correlation was found between nocebo responses and both 
anxiety scales (state and trait)12, supporting the link between anxiety and the nocebo effect.
In the current explorative study, we cannot make strong predictions on specific variables in being informative 
about other variables. Nonetheless, we could speculate that personality traits might have biased the perception of 
words and performance during the nocebo procedure, thus resulting in different perception of treatment effec-
tiveness at the end of the procedure. We know from previous literature that pessimists have a stronger attentional 
bias toward negative stimuli42 and, in a similar way, high anxiety leads to be attentive to negative events43–46. 
Based on this evidence, we could hypothesize that more anxious and less optimistic individuals deployed more 
attention to the verbal information conveyed by the experimenter about the negative effects of the treatment in 
worsening performance. Alternatively, these individuals could have paid more attention toward the progressively 
shorter cursor’s excursion range, thus amplifying the perception of the negative feedback during the conditioning 
phase. Although the current study does not allow to disambiguate between the two alternatives, we hypothesize 
that these processes could have led to a stronger perception of treatment effectiveness at the end of the nocebo 
procedure.
Some methodological limitations of the current study should be mentioned. One limit is that we cannot draw 
conclusions on the causal relation between changes in perception of treatment efficacy, personality and force 
decrements. The division of the subjects was made post-hoc, based on the difference of the treatment efficacy 
scores between the test and the conditioning sessions. In other words, we first defined a variable to divide the two 
groups, i.e., the change of subjects’ perception of treatment efficacy, and afterwards we extrapolated the disposi-
tional traits. Moreover, the mechanisms at the basis of the force decrements, sense of weakness and sense of effort 
remain to be uncover. Potential interest for future studies could be to manipulate expectation and perception of 
treatment effectiveness in a factorial design in order to investigate which factor plays a major role in the motor 
nocebo effect, similarly to the study by Peciña et al.20 in placebo analgesia.
Despite this unconventional way of proceeding, our study shows for the first time an association between 
changes in the perception of treatment effectiveness, personality traits and force production and may inspire 
further investigations aiming at explaining individual differences in the nocebo effect in motor performance.
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